BlackRock Fund Advisors’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $116K | Buy |
194
+6
| +3% | +$3.59K | ﹤0.01% | 3574 |
|
|
2016
Q3 | $213K | Hold |
188
| – | – | ﹤0.01% | 3430 |
|
|
2016
Q2 | $206K | Buy |
188
+24
| +15% | +$26.3K | ﹤0.01% | 3443 |
|
|
2016
Q1 | $211K | Sell |
164
-13
| -7% | -$16.7K | ﹤0.01% | 3444 |
|
|
2015
Q4 | $435K | Buy |
177
+6
| +4% | +$14.7K | ﹤0.01% | 3301 |
|
|
2015
Q3 | $189K | Sell |
171
-4
| -2% | -$4.42K | ﹤0.01% | 3483 |
|
|
2015
Q2 | $176K | Sell |
175
-1,334
| -88% | -$1.34M | ﹤0.01% | 3574 |
|
|
2015
Q1 | $1.53M | Sell |
1,509
-23
| -2% | -$23.4K | ﹤0.01% | 3176 |
|
|
2014
Q4 | $5.11M | Buy |
1,532
+289
| +23% | +$964K | ﹤0.01% | 2861 |
|
|
2014
Q3 | $3.6M | Sell |
1,243
-51
| -4% | -$148K | ﹤0.01% | 2937 |
|
|
2014
Q2 | $4.92M | Buy |
+1,294
| New | +$4.92M | ﹤0.01% | 2840 |
|